Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

L J OLD

Showing results (161-170 of 320) with videos related to

Pageof 32
Sort By:
Proceedings of the National Academy of Sciences of the United States of America|December 1, 1978
Expression of Ia-like antigens on cultured human malignant melanoma cell linesR J Winchester, C Y Wang, A Gibofsky, et al.
Proceedings of the National Academy of Sciences of the United States of America|May 1, 1987
Vaccines containing purified GM2 ganglioside elicit GM2 antibodies in melanoma patientsP O Livingston, E J Natoli, M J Calves, et al.
The Journal of Experimental Medicine|July 1, 1983
Detection of cell surface and intracellular antigens by human monoclonal antibodies. Hybrid cell lines derived from lymphocytes of patients with malignant melanomaA N Houghton, H Brooks, R J Cote, et al.
The Journal of Biological Chemistry|December 14, 1999
Fibroblast activation protein, a dual specificity serine protease expressed in reactive human tumor stromal fibroblastsJ E Park, M C Lenter, R N Zimmermann, et al.
Proceedings of the National Academy of Sciences of the United States of America|June 11, 1996
Serological analysis of Melan-A(MART-1), a melanocyte-specific protein homogeneously expressed in human melanomasY T Chen, E Stockert, A Jungbluth, et al.
The Journal of Experimental Medicine|September 1, 1985
High affinity binding of 125I-labeled human tumor necrosis factor (LuKII) to specific cell surface receptorsB Y Rubin, S L Anderson, S A Sullivan, et al.
Cancer Research|December 15, 1989
Characterization of IgG and IgM antibodies induced in melanoma patients by immunization with purified GM2 gangliosideP O Livingston, G Ritter, P Srivastava, et al.
Proceedings of the National Academy of Sciences of the United States of America|May 1, 1988
Cell-surface glycoproteins of human sarcomas: differential expression in normal and malignant tissues and cultured cellsW J Rettig, P Garin-Chesa, H R Beresford, et al.
Proceedings of the National Academy of Sciences of the United States of America|October 1, 1985
Purification and characterization of a human tumor necrosis factor from the LuKII cell lineB Y Rubin, S L Anderson, S A Sullivan, et al.
The Journal of Experimental Medicine|April 1, 1982
GD3, a prominent ganglioside of human melanoma. Detection and characterisation by mouse monoclonal antibodyC S Pukel, K O Lloyd, L R Travassos, et al.
Pageof 32

Showing results (161-170 of 320) with videos related to

Sort By:
Pageof 32
Proceedings of the National Academy of Sciences of the United States of America|December 1, 1978
Expression of Ia-like antigens on cultured human malignant melanoma cell linesR J Winchester, C Y Wang, A Gibofsky, et al.
Proceedings of the National Academy of Sciences of the United States of America|May 1, 1987
Vaccines containing purified GM2 ganglioside elicit GM2 antibodies in melanoma patientsP O Livingston, E J Natoli, M J Calves, et al.
The Journal of Experimental Medicine|July 1, 1983
Detection of cell surface and intracellular antigens by human monoclonal antibodies. Hybrid cell lines derived from lymphocytes of patients with malignant melanomaA N Houghton, H Brooks, R J Cote, et al.
The Journal of Biological Chemistry|December 14, 1999
Fibroblast activation protein, a dual specificity serine protease expressed in reactive human tumor stromal fibroblastsJ E Park, M C Lenter, R N Zimmermann, et al.
Proceedings of the National Academy of Sciences of the United States of America|June 11, 1996
Serological analysis of Melan-A(MART-1), a melanocyte-specific protein homogeneously expressed in human melanomasY T Chen, E Stockert, A Jungbluth, et al.
The Journal of Experimental Medicine|September 1, 1985
High affinity binding of 125I-labeled human tumor necrosis factor (LuKII) to specific cell surface receptorsB Y Rubin, S L Anderson, S A Sullivan, et al.
Cancer Research|December 15, 1989
Characterization of IgG and IgM antibodies induced in melanoma patients by immunization with purified GM2 gangliosideP O Livingston, G Ritter, P Srivastava, et al.
Proceedings of the National Academy of Sciences of the United States of America|May 1, 1988
Cell-surface glycoproteins of human sarcomas: differential expression in normal and malignant tissues and cultured cellsW J Rettig, P Garin-Chesa, H R Beresford, et al.
Proceedings of the National Academy of Sciences of the United States of America|October 1, 1985
Purification and characterization of a human tumor necrosis factor from the LuKII cell lineB Y Rubin, S L Anderson, S A Sullivan, et al.
The Journal of Experimental Medicine|April 1, 1982
GD3, a prominent ganglioside of human melanoma. Detection and characterisation by mouse monoclonal antibodyC S Pukel, K O Lloyd, L R Travassos, et al.
Pageof 32